1. Compliance and persistence in pediatric and adult patients receiving growth hormone therapy;Rosenfeld;Endocr Pract,2008
2. Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: Effects on circulating insulin-like growth factor-I and metabolic indices;Jørgensen;J Clin Endocrinol Metab,1990
3. Continuous infusion versus daily injections of growth hormone (GH) for 4weeks in GH-deficient patients;Laursen;J Clin Endocrinol Metab,1995
4. Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion versus daily injection of recombinant human GH in GH-deficient children;Tauber;J Clin Endocrinol Metab,1993
5. Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults;Laursen;J Clin Endocrinol Metab,2001